Table 3 Laboratory parameters of the COVID-19 patients and control groups
From: Long non-coding RNAs in biomarking COVID-19: a machine learning-based approach
Clinical factors | COVID-19 Group N = 28 | Control Group N = 17 |
|---|---|---|
Oxygen concentration (%) | 84.11 ± 5.93 | 94.45 ± 0.66 |
WBC (103/μL) | 6.87 ± 3.44 | 6.70 ± 1.67 |
Hb (g/dL) | 10.66 ± 1.60 | 14.27 ± 0.98 |
PLT (103/μL) | 142.47 ± 79.55 | 264.55 ± 78.02 |
FBS (mg/dL) | 144.61 ± 42.63 | 92.93 ± 5.28 |
BUN (mg/dL) | 17.55 ± 10.73 | 17.56 ± 8.20 |
Creatinine (mg/dL) | 1.43 ± 1.18 | 0.74 ± 0.09 |
Na (mEq/L) | 139.83 ± 2.99 | 140.5 ± 2.37 |
K (mEq/L) | 4.53 ± 0.71 | 4.05 ± 0.32 |
LDH (U/L) | 695.82 ± 354.95 | 213.86 ± 49.38 |
AST (U/L) | 47.2 ± 29.92 | 16.95 ± 4.04 |
ALT (U/L) | 43 ± 27.50 | 13.05 ± 3.23 |
CRP (mg/dL) | 77.22 ± 41.57 | 3.23 ± 1.24 |
ESR (mm/hour) | 47.68 ± 26.65 | 9.25 ± 5.37 |